We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative New Instrument Could Transform Oral Cancer Diagnosis

By HospiMedica International staff writers
Posted on 20 Feb 2023

Identifying lesions of the mouth (dysplasia) that have the potential to become cancerous can be a difficult task and, as a result, patients may receive unnecessary treatments or have missed cancer diagnoses. More...

Currently, dysplasia is diagnosed by examining tissue samples from patients under a microscope. This process is both time-consuming and can be subject to human error, making it unreliable. Now, an innovative new instrument currently under development could transform oral cancer diagnosis.

A research team from the University of Liverpool (Liverpool, UK) and Liverpool Head & Neck Centre (LHNC; Liverpool, UK) is developing the Liverpool Diagnostic Infrared (LDIR) Wand, a hand-held device that can rapidly and accurately identify lesions in the mouth that will develop into cancer. The LDIR wand uses a small number of infrared lasers, combined with machine learning algorithm analysis of infrared spectral images of tissue, to identify the lesions in the mouth that are not currently malignant but will become malignant in the future. The researchers will initially develop a prototype of the LDIR Wand for use in histopathology laboratories that could eventually be used in clinics for real-time diagnostics.

“This instrument addresses a difficult clinical problem in head and neck cancer diagnosis,” said Professor Richard Shaw from the LHNC. “We know that earlier diagnosis is key to saving lives, but predicting cancer risk in oral patches is problematic. For some patients we miss a high risk of cancer developing, but for other patients we cannot safely reassure them without better information”

Related Links:
University of Liverpool
LHNC


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.